Cadence Capital Management’s MacroGenics MGNX Stock Holding History

Cadence Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-33,438	Closed	-$1.27M	–	629
2015 Q2	$1.27M	Buy	33,438 +18,458	+123%	+$607K	0.07%	351
2015 Q1	$470K	Buy	+14,980	New	+$508K	0.03%	514

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Cadence Capital Management's MGNX Position: Q3 2015 in Review

Cadence Capital Management sold out of MacroGenics (MGNX) in Q3 2015, closing a stake of 33,438 shares — an estimated $1.27M sold.

Cadence Capital Management first reported a position in MGNX in Q1 2015 and held it in 2 quarters. The position peaked at $1.27M in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q3 2015.

Cadence Capital Management reported no remaining MacroGenics position as of Q3 2015 after selling out during the quarter.
Cadence Capital Management sold 33,438 MacroGenics shares in Q3 2015, an estimated $1.27M.
Cadence Capital Management first reported a position in MacroGenics in Q1 2015 and held it in 2 quarters.
Cadence Capital Management's MacroGenics position peaked at $1.27M in Q2 2015.
125 funds tracked by Wall St. Rank held MacroGenics as of Q3 2015.

Based on Cadence Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.